Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers, Two Batches of Symbicort Turbuhaler and Budesonide/Formoterol Easyhaler: Randomised, Double-blind, Double-dummy, Single Centre, Single Dose, Crossover Study in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 18 May 2017
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Acronyms REFLI
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2012 New trial record
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.